Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9345785 Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates

Patent 9345785 was granted and assigned to Seagen on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 26 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12016842 Methods of using anti-CD79b immunoconjugates
0
Edits on 12 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+388 characters)
Article

Patent abstract

Disclosed are anti-CD70 antibodies and derivatives thereof conjugated to cytotoxic, therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody- and antibody derivative-drug conjugates. Also disclosed are methods, for the treatment of CD70-expressing a cancer, comprising administering to a subject the disclosed pharmaceutical compositions.

Edits on 29 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 29 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alan F. Wahl0
Che-Leung Law0
Linda A. Pestano0
Nathalie Scholler0
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093457850
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09345785 Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates US Patent 9345785 Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates

Infobox
Patent Number
093457850
Patent Number
93457850
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Seagen
Seagen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
093457850
Date of Patent
May 24, 2016
0
Patent Application Number
126356070
Date Filed
December 10, 2009
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093457850
Patent Primary Examiner
‌
Laura B Goddard
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09345785
Edits on 6 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 6 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09345785 Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates

Infobox
Is a
Patent
Patent
Current assignee
Seagen
Seagen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09345785
Date of patent
May 24, 2016
Patent application number
12635607
Date Filed
December 10, 2009
Patent primary examiner
‌
Laura B Goddard

Find more entities like US Patent 9345785 Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.